Abstract Albuminuria, the abnormal presence of albumin in urine, is a key marker of kidney damage and a strong predictor of kidney and cardiovascular outcomes. Its clinical significance has evolved from early historical observations to its current role in chronic kidney disease (CKD) detection, risk stratification and treatment monitoring.
Jelle M. Beernink+4 more
wiley +1 more source
Sodium-dependent glucose transporter 2 inhibitors improve heart function in patients with type 2 diabetes and heart failure. [PDF]
Zhang YF, Liu YX, Yang WX.
europepmc +1 more source
The interplay between heart failure and chronic kidney disease
Abstract Chronic kidney disease (CKD) and heart failure (HF) are two globally prevalent, independent, long‐term conditions, which often coexist in an individual and display a bidirectional yet interconnected relationship. The presence of CKD often leads to the development of HF and vice versa, which propagates the worsening of each disease, reflecting ...
Anuradha Lala+2 more
wiley +1 more source
Highlights of the Most Recent American Diabetes Association Guidelines: From Evidence to Practice. [PDF]
Kim MK.
europepmc +1 more source
Abstract Aims To describe temporal changes in the characteristics of medication‐initiator cohorts in persons with chronic kidney disease (CKD) and type 2 diabetes (T2D). Materials and Methods Adults with CKD and T2D initiating sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) or glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) were identified in ...
Yuichiro Yano+9 more
wiley +1 more source
Trends in prescribing sodium-glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular-renal disease in South Korea, 2015-2021. [PDF]
Ha KH, Shin S, Na E, Kim DJ.
europepmc +1 more source
Long‐term adherence to glucose‐lowering medications in adults with diabetes: A data linkage study
Abstract Aims To determine the adherence rate in users of each class of glucose‐lowering medication and identify the key socio‐demographic factors influencing adherence. Methods The 45 and Up Study is an ongoing cohort study of residents aged ≥45 years in New South Wales, Australia.
Crystal M. Y. Lee+3 more
wiley +1 more source
Comparative effectiveness of insulin glargine, glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in veterans with type 2 diabetes. [PDF]
Shen J+14 more
europepmc +1 more source
Abstract Aims To investigate the association between type 2 diabetes and all‐cause mortality in people with ischaemic and non‐ischaemic heart failure (HF). Methods Using the Clinical Practice Research Datalink primary care data, linked to hospital and mortality records, we identified newly diagnosed adults with type 2 diabetes between 2000 and 2021 and
Kajal Panchal+4 more
wiley +1 more source
Age-dependent effects of SGLT2 inhibitors on stroke risk in geriatric patients with diabetes and atrial fibrillation. [PDF]
Chua SK+8 more
europepmc +1 more source